EVORX TECHNOLOGIES, INC.

Medtech

PET imaging tracer (EVO-004) — a radiolabeled cyclic peptide for detecting HER2-positive breast cancer

Grants
$2.0M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
10
1 granted · 9 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer$855,568
Federal grantDepartment of Health and Human Services · Phase II · Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer$1,144,342
Federal grantDepartment of Health and Human Services · Phase II · Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer$3,090
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1853ADAVANCE NANOLYTICS INC——
1854BIOSCIENCE DEVELOPMENT, INC.——
1855INSIGHTFIL——
1856EVORX TECHNOLOGIES, INC.——
1857PZA INNOVATION LLC——
1858Altrix Medical, Inc.——
1859BULLSEYE BIODEVICES, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 10
  • Methods And Compositions For Controlling Gene Expression And Treating Cancergranted
  • Barcoded Peptidesapplication
  • HER-2-SPECIFIC Cyclized Supr Peptidesapplication
  • Beta-catenin Barcoded Peptidesapplication
  • HER-2-SPECIFIC Cyclized Supr Peptidesapplication
  • Barcoded Peptidesapplication
  • Methods And Compositions For Controlling Gene Expression And Treating Cancerapplication
  • Beta-catenin Barcoded Peptidesapplication
  • Barcoded Peptidesapplication
  • Azide Scavenging Resinapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.